Sumitomo Mitsui Trust Holdings, Inc. Bluebird Bio, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 27, 2020	SELL	$27.12 - $45.97 $2.88 Million - $4.88 Million	-106,151 Closed	0 $0
Q1 2020 Apr 27, 2020	SELL	$26.16 - $63.5 $3.73 Million - $9.05 Million	-142,568 Reduced 57.32%	106,151 $4.88 Million
Q4 2019 Jan 31, 2020	BUY	$46.96 - $61.67 $4.25 Million - $5.58 Million	90,546 Added 57.24%	248,719 $21.8 Million
Q3 2019 Oct 31, 2019	BUY	$59.47 - $93.1 $1.45 Million - $2.27 Million	24,387 Added 18.23%	158,173 $14.5 Million
Q2 2019 Jul 29, 2019	BUY	$75.84 - $105.21 $2.9 Million - $4.02 Million	38,199 Added 39.96%	133,786 $17 Million
Q1 2019 May 08, 2019	BUY	$64.44 - $104.11 $6.16 Million - $9.95 Million	95,587 New	95,587 $15 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.